Oncology Institute Inc [NASDAQ: TOI] stock went on an upward path that rose over 18.60% on Thursday, amounting to a one-week price increase of more than 17.62%.
Over the last 12 months, TOI stock rose by 828.80%. The one-year Oncology Institute Inc stock forecast points to a potential upside of 59.0. The average equity rating for TOI stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $263.79 million, with 88.93 million shares outstanding and 45.65 million shares in the current float. Compared to the average trading volume of 1.80M shares, TOI stock reached a trading volume of 5633814 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Oncology Institute Inc [TOI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TOI shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TOI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Oncology Institute Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 15, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on February 26, 2024, representing the official price target for Oncology Institute Inc stock. Previously, the target price had yet another raise to $7, while Guggenheim analysts kept a Buy rating on TOI stock.
The Price to Book ratio for the last quarter was 50.35, with the Price to Cash per share for the same quarter was set at 0.43.
TOI Stock Performance Analysis:
Oncology Institute Inc [TOI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.62. With this latest performance, TOI shares gained by 10.38% in over the last four-week period, additionally plugging by 809.96% over the last 6 months – not to mention a rise of 828.80% in the past year of trading.
Insight into Oncology Institute Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Oncology Institute Inc [TOI] shares currently have an operating margin of -12.91% and a Gross Margin at 13.07%. Oncology Institute Inc’s Net Margin is presently recorded at -13.10%.
Return on Equity for this stock declined to -28.66%, with Return on Assets sitting at -28.66%.
Oncology Institute Inc [TOI] Institutonal Ownership Details
There are presently around $34.63%, or 38.15% of TOI stock, in the hands of institutional investors. The top three institutional holders of TOI stocks are: FMR LLC with ownership of 4.75 million shares, which is approximately 6.4005%. DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), holding 3.36 million shares of the stock with an approximate value of $$1.55 million in TOI stocks shares; and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), currently with $$0.82 million in TOI stock with ownership which is approximately 2.4025%.
